Fact-checked by Grok 2 weeks ago

Quackery

Quackery denotes the promotion of fraudulent or unsubstantiated medical practices and remedies, typically by unqualified practitioners who assert efficacy without empirical validation or plausible mechanisms. The term originates from the kwakzalver, describing itinerant sellers of salves who loudly proclaimed their wares' miraculous properties in public markets, a practice rooted in medieval hawking traditions. Historically intertwined with the evolution of , quackery flourished in eras lacking systematic regulation and scientific scrutiny, preying on patients' vulnerabilities through exaggerated claims of cures for ailments from cancer to . Its defining characteristics include reliance on anecdotal testimonials over controlled trials, dismissal of causal evidence requirements, and exploitation of effects or natural remission to feign success, often resulting in direct physiological from toxic substances, financial depletion, and critical delays in accessing evidence-based interventions. In contemporary contexts, quackery persists via pseudoscientific modalities such as unverified herbal cures or energy therapies, underscoring ongoing challenges in distinguishing them from legitimate inquiry despite advancements in evidence-based standards. Notable controversies highlight its societal costs, including eroded in healthcare and amplified risks during health crises when desperate individuals forgo proven treatments for illusory hopes.

Definition and Terminology

Core Definition

Quackery denotes the fraudulent or pseudoscientific promotion of health products, services, or practices purporting to diagnose, treat, or cure diseases without a plausible biological or substantiation through empirical testing. Core to this phenomenon is the advancement of interventions that contradict verifiable causal pathways in human physiology, such as claims of universal cures for conditions like cancer or via untested herbal extracts or devices, often prioritizing profit over patient outcomes. Distinguishing quackery from genuine medical progress hinges on methodological rigor: legitimate innovations demand evidence from randomized controlled trials demonstrating reproducible efficacy and safety via , whereas quackery substitutes testimonials, selective anecdotes, or unfalsifiable theories for such validation. This reliance on non-empirical appeals evades scrutiny of underlying mechanisms, frequently resulting in delayed effective care and direct harm, as evidenced by 19th-century tonics like Fowler's solution, which were touted for ailments from to but induced chronic poisoning, manifesting in gastrointestinal distress, , and elevated mortality from toxicity in prolonged users.

Etymology and Historical Terms

The term "quack" derives from the obsolete "quacksalver," first attested in the 1570s, literally meaning "hawker of " from "quacke" () and "salven" (to rub with ointment), with "quacke" implying boastful promotion akin to quacking. This referred to itinerant vendors who loudly touted mercury-based ointments and other unproven remedies, often applied to ailments, whose empirical inefficacy—evidenced by and lack of therapeutic effect—distinguished them from legitimate practitioners. By the early , "quack" shortened the term in English usage around the 1630s to denote "impudent and fraudulent pretender to medical skill," emphasizing deceptive salesmanship over any substantive knowledge. "Quackery," as the noun for such fraudulent practices, emerged concurrently in the 1630s, encapsulating the promotion of bogus treatments without verifiable , a connotation rooted in the observable failures of hawked nostrums to deliver claimed results. Historical synonyms evolved similarly from performative deception; for instance, "" entered English in the early via from "ciarlatano," derived from "ciarlare" (to prattle or chatter), originally describing loquacious street sellers who babbled exaggerated virtues of ineffective elixirs to attract crowds. Alternative etymologies link it to "cerretano," inhabitants of Cerreto known for peddling spurious wares, underscoring the term's association with unverifiable claims that crumbled under scrutiny. In legal and regulatory discourse by the early , "health " supplanted or paralleled "quackery" to denote deliberate misrepresentation of products' , particularly after exposures of medicines' baseless assertions, though the core linguistic emphasis remained on empirically unsubstantiated pretensions rather than mere error. These terms' reflects a consistent demarcation: promoters whose remedies failed causal tests of , as opposed to evidence-based methods, avoiding dilution into labels for unproven but non-fraudulent innovations.

Historical Origins and Evolution

Pre-Modern and Early Modern Periods

In ancient civilizations, medical practices often blended empirical observations with unverified claims, laying early foundations for quackery amid limited scientific validation. , such as the dating to around 1550 BCE, prescribed remedies like willow bark infusions for ailments including colic, , and earaches, derived from traditional uses without systematic efficacy testing. While willow bark contained —a precursor to aspirin with properties—its promotion as a broad cure-all lacked causal verification, exemplifying promotion of partially effective but overhyped treatments in an era of ritualistic healing. Similarly, in , itinerant healers and charlatans peddled unproven balms and potions to the populace, often exploiting the illiterate and poor, while gladiators' sweat was marketed as a medicinal despite no demonstrated therapeutic value beyond or coincidental effects. During the medieval period, quackery proliferated in response to catastrophic events like the (1347–1351), which killed an estimated 30–60% of Europe's population, creating vacuums filled by opportunistic itinerant healers. These charlatans sold amulets, herbs, and bogus cures—such as carrying toasted bread or wearing pouches of aromatic substances—claiming protection against the , even as physicians often fled cities, leaving desperate communities vulnerable to . Empirical outcomes underscored the inefficacy: despite widespread use of untested herbal concoctions, mortality rates remained devastatingly high, with no verifiable reduction attributable to these interventions, highlighting causal fallacies in attributing survival to superstitious or anecdotal remedies. In Renaissance and early modern Europe (roughly 1400–1700), itinerant mountebanks and empirics intensified quackery by performing theatrical demonstrations of dubious ointments and elixirs in public squares, particularly in Italy and France, where regulatory oversight was minimal. These practitioners, often self-proclaimed experts, capitalized on the era's medical pluralism—where humoral theory dominated but lacked rigorous testing—hawking treatments like mercury-based salves for syphilis, which caused more harm through toxicity than benefit, as evidenced by contemporary accounts of patient deterioration. Rare validations, such as willow bark's persistent folk use eventually informing salicylic acid isolation in the 19th century, contrasted with predominant fraud, where promoters exaggerated efficacy without empirical controls, perpetuating high failure rates in an age of pre-scientific medicine. This period's patterns of deceit persisted due to information asymmetries and societal tolerance for unproven healers amid genuine knowledge gaps.

19th and Early 20th Centuries

The 19th century saw a surge in patent medicines in the United States, driven by industrialization, expanded advertising, and limited regulation, transforming quackery into a mass-market enterprise. These proprietary remedies, often secret formulas sold without prescriptions, proliferated with claims to cure serious ailments like cancer, tuberculosis, and rheumatism, despite lacking empirical validation. By the late 1800s, the industry had become substantial, with manufacturers producing thousands of branded tonics, many containing high levels of alcohol—sometimes exceeding 40%—or opium derivatives like morphine, undisclosed to consumers and contributing to widespread addiction rather than therapeutic benefit. Such products exemplified consumer-targeted frauds, capitalizing on public desperation amid high disease mortality and nascent scientific medicine. Empirical harms were evident, as many tonics provided no curative effects for advertised conditions, instead masking symptoms through palliation or causing direct , including infant deaths from opium-laced "soothing syrups." Post-enactment analyses after revealed that the majority of these remedies were ineffective for their bold claims, with undisclosed addictive substances posing greater risks than benefits in most cases. The shift toward industrialized production amplified these dangers, as aggressive marketing via newspapers and almanacs reached millions, often preying on vulnerable populations without accountability. Key regulatory responses emerged in response to exposés, including Upton Sinclair's 1906 novel , which, while focused on meatpacking insanities, galvanized public outrage leading to the . This legislation mandated accurate labeling of ingredients and prohibited misbranded drugs in interstate commerce, curtailing the most egregious abuses by requiring disclosure of alcohol and narcotics content, though it fell short of banning false efficacy claims outright. Concurrently, the (AMA) intensified campaigns against pseudoscientific devices, such as ' "electronic reactions" machines introduced in the 1910s, which purported to diagnose diseases via vibrational analysis but were debunked as fraudulent through controlled tests revealing reliance on suggestion and sleight-of-hand. The 1910 further advanced scientific standards by critiquing substandard medical schools, resulting in the closure of numerous quack-oriented institutions and bolstering over empirical frauds.

Mid-20th Century to Present

In the post-World War II era, quackery adapted to stricter U.S. regulations, such as the 1962 Kefauver-Harris Amendments requiring proof of efficacy for new drugs, by shifting toward unproven "natural" remedies and cancer treatments marketed outside formal approval processes. Despite these measures, fraudulent claims persisted, often leveraging and patient desperation; for instance, Krebiozen, promoted since 1951 as a cancer cure derived from horse serum, was analyzed by FDA chemist Alma LeVant Hayden in 1956, revealing it to be merely , a common muscle metabolite with no therapeutic value. Clinical investigations in the early , including controlled trials by the FDA and , confirmed its ineffectiveness against tumors, leading to fraud convictions against promoters like Stevan Durovic in 1966. The and also saw a surge in "health food" promotions, exemplified by figures like Gayelord Hauser advocating raw foods, yogurt, and yeast supplements as panaceas for chronic diseases, often without empirical support and criticized by authorities for overstating benefits amid rising consumer interest in preventive nutrition. By the 1970s, such fads intertwined with demands for access to unapproved therapies, as seen with laetrile ( from apricot kernels), aggressively marketed as for cancer despite lacking ; the FDA banned interstate shipment in 1977 after preclinical showed from release without antitumor effects. A 1981 National Cancer Institute-sponsored trial involving 178 patients found no improvements in survival or symptom relief compared to controls, confirming inefficacy and prompting further restrictions. From the 1980s onward, quackery integrated into burgeoning wellness movements, adopting scientific veneer through terms like "holistic" and "complementary" while resisting rigorous testing; randomized controlled trials (RCTs) repeatedly demonstrated inefficacy for many claims, such as for , where a 2013 NIH trial of 1,708 patients showed no reduction in cardiovascular events versus . Globalization facilitated cross-border promotion, with treatments like laetrile clinics in drawing U.S. patients despite bans, underscoring regulatory challenges in tracking international . Persistence is evident in market data: U.S. spending on alternative therapies rose from $13.7 billion in 1997 to over $30 billion by 2012, often for unproven interventions amid toward pharmaceuticals. In recent decades, the highlighted quackery's resilience, with hyped in early 2020 based on antiviral data and small observational studies suggesting potential benefits. However, large-scale RCTs, including the UK's trial (over 11,000 patients) in June 2020 and the WHO's trial (later analyses), clarified no mortality reduction and possible cardiac risks, leading WHO and FDA to revoke emergency authorizations by mid-2020. These episodes reflect quackery's pattern of exploiting preliminary or misinterpreted data before empirical refutation, persisting globally despite enhanced .

Characteristics of Quackery

Common Methods and Tactics

Quackery often relies on anecdotal testimonials and personal success stories in place of controlled clinical trials or peer-reviewed evidence to promote treatments. These narratives, frequently presented as genuine user experiences, substitute subjective reports for empirical validation, ignoring effects, , and the absence of randomized, double-blind studies. Promoters commonly make sweeping promises of "miracle cures" or rapid remedies for complex, multifaceted such as cancer or , disregarding established pathophysiological mechanisms and the need for long-term data. Such claims bypass the inherent variability of progression and individual responses, asserting effectiveness without supporting mechanistic explanations or dose-response relationships. A hallmark tactic involves deploying scientific-sounding jargon—such as "," "bioenergetic fields," or "nanoparticle detoxification"—to confer an aura of legitimacy, despite lacking falsifiable hypotheses, reproducible experiments, or alignment with established physics and . This misuse of terminology exploits public unfamiliarity with technical concepts, evading scrutiny by invoking undefined or pseudoscientific constructs without empirical backing. Distribution frequently occurs through multi-level marketing (MLM) structures for supplements and devices, where recruitment of distributors generates revenue streams prioritizing sales volume over product safety or efficacy verification. These models incentivize exaggerated claims to drive downline expansion, often resulting in undisclosed financial conflicts and proliferation of unvetted products. Verifiable indicators include the consistent absence of independent, peer-reviewed randomized controlled trials demonstrating superiority over placebo or standard care, coupled with underreporting or concealment of adverse events. For instance, in the 2020s, the FDA has issued multiple recalls for dietary supplements adulterated with undeclared pharmaceuticals like sildenafil and sibutramine, highlighting tactics to mask risks while claiming natural safety.

Psychological and Marketing Appeals

Quackery persists partly due to psychological vulnerabilities, particularly among individuals facing desperation from chronic or terminal illnesses, where hope for cures overrides toward unproven claims. Patients in such states are susceptible to appeals promising rapid relief or reversal of dire prognoses, as evidenced by analyses of quack promoters exploiting human tendencies toward and . A key cognitive factor is the naturalness bias, wherein individuals prefer "natural" remedies over synthetic pharmaceuticals, even when the former lack superior efficacy or safety. This bias manifests in health decisions, with studies showing preferences for natural drugs or vaccines despite identical compositions to artificial counterparts, rooted in perceptions of purity and reduced risk. Such inclinations fuel quackery's appeal against perceived "Big Pharma" interventions, amplified by documented pharmaceutical scandals like the opioid crisis, which eroded trust and positioned alternative options as underdog solutions. Marketing tactics in quackery leverage fear-mongering about side effects of evidence-based treatments while downplaying risks of unverified alternatives, often through anecdotal testimonials that evoke emotional resonance over empirical data. Surveys indicate complementary and alternative medicine (CAM) use has risen to 36.7% of U.S. adults by 2022, with distrust of pharmaceutical companies cited as a primary driver among users seeking autonomy from conventional systems. This dynamic is causally linked to market asymmetries, where regulatory barriers favor patented drugs, inadvertently enhancing the allure of unregulated "natural" products—some of which, like turmeric's curcumin, show preliminary anti-inflammatory evidence but are routinely oversold beyond validated limits.

Notable Historical Examples

Patent Medicines and Snake Oil

medicines, proprietary formulations marketed directly to consumers in the 19th and early 20th centuries, typically evaded ingredient disclosure and efficacy proof, relying on bold claims for ailments ranging from pain to chronic diseases. In the United States and , prior to regulatory interventions like the 1906 , these products often comprised alcohol, herbal extracts, or inert substances, with sales driven by testimonials and aggressive rather than clinical . The term "," emblematic of fraudulent remedies, traces to Clark Stanley's , launched circa 1893 after Stanley's demonstrations at the . Stanley asserted the , purportedly derived from fat learned from medicine men, instantly relieved , , , and lameness through external application. No controlled trials validated these assertions; the preparation's effects, if any, stemmed from capsaicin-like irritants rather than snake components. In 1917, federal analysis under the exposed its composition as 99% with beef fat, ammonia water, and , devoid of snake oil, resulting in a $4,000 fine and cessation of misbranded sales. Another prominent example, Lydia E. Pinkham's Vegetable Compound, debuted in 1875 as a tonic for "female complaints" including menstrual irregularities, cramps, and menopausal symptoms. Formulated with herbs such as black cohosh, life root, and root in a 20-28% base, it promised to restore ovarian function and alleviate . analyses post-regulation revealed no active therapeutic agents beyond the sedative and vasodilatory effects of alcohol, equating benefits to at best; the product's success hinged on via almanacs and Lydia Pinkham's as a sympathetic matron. Certain medicines inflicted direct harm through . Radium-laced waters, such as introduced around 1918, were distilled with radium-226 and radium-228 isotopes, marketed as invigorators for over 150 conditions including impotence and by stimulating . Empirical evidence of inefficacy emerged via radiation-induced pathologies; consumption led to jaw necrosis, , and organ failure, exemplified by ' death in 1932 after ingesting 1,400 bottles, with confirming poisoning as the cause. The American Medical Association's investigations from onward, detailed in Nostrums and Quackery volumes, cataloged hundreds of fatalities between 1900 and 1920 from elixirs contaminated with , undeclared opiates, or radioactive elements, underscoring the absence of testing.

Specific Fraudulent Practitioners

John R. Brinkley (1885–1942) gained notoriety for performing thousands of xenotransplantations of goat testicular glands into human patients, primarily claiming to treat male impotence and prostate issues, beginning around 1918 in Milford, Kansas. These procedures, priced at $750 each (equivalent to approximately $16,500 in 2024 dollars), often resulted in severe infections, hemorrhages, and deaths due to surgical incompetence and lack of sterile technique, with estimates of dozens of fatalities linked to complications. Physicians testifying in described the operations as fraudulent, noting no physiological basis for the claimed effects and highlighting Brinkley's use of diluted dyes passed off as proprietary medicines. Brinkley promoted his treatments via his radio station KFKB, established in 1923, where he broadcast testimonials and medical advice to attract patients nationwide, amassing significant wealth before regulatory intervention. In June 1930, the declined to renew KFKB's license, citing misuse for quackery promotion, and in September 1930, the Kansas State Medical Board revoked Brinkley's license for gross immorality and unprofessional conduct following patient complaints and investigations. Subsequent lawsuits for , wrongful death, and , alongside federal probes into mail fraud and , forced Brinkley to relocate operations to , where he continued via border-blaster station XER until his death. Wilhelm Reich (1897–1957) transitioned from to developing "" energy theory in , constructing accumulators—enclosed wooden cabinets lined with metal—for purportedly harnessing cosmic life energy to treat cancer and other diseases, claiming tumor shrinkage in observational cases without controlled validation. The U.S. initiated investigations in 1947 after reports of interstate sales, conducting laboratory tests from 1950–1952 that failed to detect measurable energy or therapeutic effects, leading to a 1954 federal injunction prohibiting manufacture, distribution, or promotion of the devices as curative. Reich's refusal to comply, viewing the injunction as suppression of truth, resulted in a 1956 contempt conviction and two-year prison sentence, during which over six tons of his publications and equipment were destroyed by court order on August 23, 1956. While Reich's early psychoanalytic contributions, including emphasis on muscular armoring and as extensions of Freudian theory, influenced subsequent therapies, his orgone devices demonstrated no empirical in evaluations, with results in and measurements undermining causal claims of biological influence. died of in on November 3, 1957, prior to completing his term, leaving therapy discredited in scientific circles despite anecdotal defenses from followers.

Early Legislative Efforts

In , early efforts to curb quackery through legislation focused on restricting the sale of poisons and medicines by unqualified individuals. The Pharmacy Act of 1852 established a register of pharmaceutical chemists and restricted the sale of certain poisons to qualified practitioners, aiming to professionalize dispensing and reduce fraudulent sales. This was expanded by the Pharmacy Act of 1868, which created the Pharmaceutical Society's council with powers to regulate pharmacy practice and prosecute unqualified sellers of scheduled poisons, responding to widespread nostrum vending that often involved hazardous adulterated products. These acts targeted overt quackery by limiting access to dangerous substances but did not broadly prohibit false efficacy claims, allowing proprietary medicines to persist via rephrased advertising. Similar restrictions appeared in other European contexts, though enforcement varied. In during the mid-19th century, statutes under the Medical Department of the Ministry of Internal Affairs imposed penalties for unlicensed practice and false therapeutic , building on Petrine-era edicts against charlatans; violators faced fines or , particularly for itinerant healers peddling unproven cures during epidemics. Pre-legislation data from the 1840s cholera outbreaks documented rampant unauthorized remedies, with post-statute reports indicating fewer public claims but continued underground distribution through informal networks. In the United States, the Pure Food and Drug Act of 1906 marked a pivotal federal response to patent medicine frauds exposed by investigations like Samuel Hopkins Adams' 1905 Collier's series, which revealed widespread adulteration and mislabeling in over 500 nostrums. The act prohibited interstate commerce of misbranded or adulterated drugs, mandating accurate ingredient labeling but exempting therapeutic claims from efficacy requirements, thus addressing composition fraud without verifying curative value. Analyses from the 1910s, including American Medical Association reviews, showed a measurable decline in overt advertisements claiming miraculous cures—magazine patent medicine promotions dropped by approximately 40% in volume from 1906 to 1912—yet fraudulent products endured through subtle rewording or local sales, underscoring the law's causal limitations in eradicating deceptive practices. This partial effectiveness prompted subsequent amendments, but early data confirmed persistence in non-interstate channels.

Modern Regulatory Frameworks

In the United States, the (FDA) and (FTC) enforce regulations against quackery primarily through oversight of unapproved products and deceptive advertising. The 1962 Kefauver-Harris Amendments established requirements for drug manufacturers to demonstrate via adequate and well-controlled clinical investigations, shifting from mere safety assessments to evidence-based validation. The FDA targets health fraud by maintaining a database of over 1,000 violative products and issuing warning letters for related to diseases or conditions. During the early 2020s , the agencies intensified actions against unproven treatments, including seizures of fraudulent devices and injunctions against promoters of fake cures like unapproved supplements claiming viral prevention. The FTC complements this by challenging false claims, with over 200 enforcement actions since 1998 against dietary supplements and similar products lacking competent scientific support. Globally, regulatory frameworks vary, with the (WHO) providing guidelines to combat falsified medicines and fraudulent traditional remedies through enhanced and international cooperation. In countries like , the regulates alternative systems such as , , and Unani under the Drugs and Cosmetics Act, requiring licensing for manufacture and sale while mandating compliance with quality standards like those in Drugs Rules 1945 Rule 158-B. This oversight aims to balance promotion of traditional practices with prevention, including requirements for claims and collaboration with bodies like WHO for . Enforcement data highlight compliance gaps and potential biases, as pharmaceutical firms have incurred $62.3 billion in U.S. settlements from 1991 to 2021 for offenses like off-label promotion, exemplified by Pfizer's $2.3 billion payment in 2009—the largest settlement to date—while penalties against fraud typically range in the low millions. Such disparities indicate uneven application, where large entities absorb fines without operational disruption, contrasting with more aggressive shutdowns of small-scale quack operations despite the FDA identifying thousands of ongoing fraudulent products.

Controversies and Debates

Harms and Empirical Evidence of Fraud

Quackery frequently results in delayed or abandoned conventional treatments, exacerbating outcomes for serious conditions. A 2017 cohort study of 1,290 cancer patients with nonmetastatic , , colon, or found that those selecting as initial treatment—such as special diets, , or —experienced a 2.5-fold higher of over five years compared to those receiving conventional care like , , or . This elevated mortality persisted across cancer types and after adjusting for factors like , , and comorbidities, with five-year survival rates dropping from 86.6% for conventional treatment users to 54.7% for alternative-only users. Illustrative cases underscore causal links between quackery and adverse progression. Apple co-founder , diagnosed with a resectable in October 2003, deferred surgery for nine months, pursuing alternative modalities including vegan diets, , and bowel cleanses despite medical advice. Jobs later expressed regret to his biographer, stating the delay was a mistake that permitted ; the tumor, initially localized and surgically treatable with high survival odds, had spread by July 2004, contributing to his death from metastatic complications in October 2011. Financial exploitation compounds these risks, as quackery diverts resources from evidence-based care. The global complementary and market, encompassing quack remedies marketed with unsubstantiated claims, reached $179.17 billion in 2024. Regulatory interventions yield limited redress; for instance, U.S. actions against fraudulent health claims, including those in alternative therapies, have resulted in multimillion-dollar settlements, but these represent a fraction of consumer outlays on ineffective products. Empirical audits of quack schemes, such as deceptive homeopathic advertising, reveal systematic misrepresentation of efficacy, leading to unrecoverable losses without corresponding health benefits.

Accusations of Overreach and Suppression of Alternatives

Critics of mainstream medical regulation contend that labels of quackery have occasionally extended beyond fraudulent practices to suppress non-pharmaceutical alternatives, potentially stifling innovation and patient choice in favor of established interests. Historical instances include organized medicine's efforts to marginalize care, which originated in the late as a for musculoskeletal issues. The (AMA) initiated a coordinated campaign in the 1960s, known as the "Iowa Plan," aimed at containing chiropractic's growth through professional boycotts, ethical restrictions on physician referrals, and portrayal of practitioners as unscientific competitors. This culminated in the 1976 antitrust lawsuit , where a federal court ruled in 1987 (upheld on appeal in 1990) that the AMA had violated the by conspiring to eliminate chiropractic as a viable healthcare option, reflecting elements of by incumbent providers. Such opposition persisted into the mid-20th century despite emerging evidence, with the maintaining policies against collaboration until court-mandated changes. Subsequent randomized controlled trials (RCTs) have demonstrated spinal manipulative therapy's efficacy for , yielding moderate short-term pain relief comparable to or recommended conventional treatments, based on analyses of over 1,000 patients across multiple studies. Detractors argue this delay illustrates paternalistic overreach, prioritizing guild protection over empirical validation and , where low-risk interventions could complement standard care without undermining pharmaceutical revenues. Similar accusations arise regarding , a traditional needle-based technique long dismissed by authorities as despite its low adverse event profile. Early regulatory skepticism, influenced by biomedical paradigms favoring drug interventions, limited integration until systematic reviews aggregated data from dozens of RCTs showing acupuncture's superiority over sham controls for conditions, with effect sizes indicating meaningful relief in musculoskeletal and neuropathic cases involving thousands of participants. Proponents of alternatives claim economic incentives drive such suppression, as pharmaceutical lobbying—exceeding $300 million annually in recent U.S. sessions—focuses on extending monopolies and restricting competitor pathways, indirectly marginalizing non-patentable options like herbal or manual therapies that challenge high-margin synthetics. This dynamic, critics assert, favors causal mechanisms rooted in market incumbency over patient-centered evidence, where viable low-cost alternatives are preemptively branded quackery to maintain revenue streams from approved modalities.

Cases of Mainstream Errors vs. Alternative Validations

The withdrawal of (Vioxx) by Merck on September 30, 2004, followed clinical evidence linking the COX-2 inhibitor to increased risks of and , with FDA estimates indicating approximately 27,000 to 60,000 excess heart attacks and sudden cardiac deaths in the United States from 1999 to 2004. This occurred despite initial approval in 1999 and promotion as a safer alternative to traditional NSAIDs, highlighting failures in post-market surveillance and within pharmaceutical development. Similarly, the aggressive marketing of extended-release (OxyContin) by starting in 1996, backed by claims of low addiction risk, contributed to the U.S. , resulting in over 760,000 opioid-involved overdose deaths from 1999 through 2022 according to CDC data. In contrast, , derived from the sweet wormwood plant () through screening of ancient Chinese herbal texts during in the 1970s, emerged as a highly effective antimalarial agent, earning the 2015 in Physiology or Medicine for its discovery rooted in . Initially overlooked by Western , artemisinin-based combination therapies now form the WHO-recommended first-line treatment for Plasmodium falciparum , saving millions of lives annually in endemic regions. Likewise, , long classified as a Schedule I substance under the 1970 with no accepted medical use, saw validation through FDA approval of Epidiolex ( oral solution) in June 2018 for seizures in Lennox-Gastaut and Dravet syndromes, following rigorous clinical trials demonstrating efficacy. This shift reflects empirical overturning of prior dismissals, with ongoing rescheduling proposals to Schedule III acknowledging therapeutic potential amid historical stigmatization as quackery. Recent randomized controlled trials (RCTs) on psychedelics further illustrate reevaluations of previously marginalized substances; received FDA designation in 2017 for severe PTSD after phase 2 trials showed 67% of participants no longer meeting diagnostic criteria post-treatment, prompting phase 3 studies in the early 2020s that reported significant symptom reductions despite subsequent regulatory hurdles. These cases underscore instances where empirical data from controlled studies challenged initial orthodox rejections, questioning rigid categorizations of quackery and emphasizing the need for causal evidence over institutional priors in distinguishing valid therapies from fraud.

Modern and Digital Manifestations

Global Prevalence in Developing Regions

In developing regions, quackery persists due to limited regulatory oversight, widespread reliance on traditional healers amid scarce modern healthcare infrastructure, and cultural preferences for affordable, accessible alternatives. According to (WHO) estimates, approximately 80% of populations in rural areas of low- and middle-income countries depend on for primary needs, often turning to herbal remedies and healers when formal systems are overburdened or distant. This reliance, driven by economic barriers and trust in practices, creates fertile ground for fraudulent interventions, where unverified claims of blend with genuine cultural traditions, exacerbating risks without empirical validation. In and , government-promoted traditional systems like , , Unani, , and (AYUSH) and (TCM) face infiltration by adulterated products and unsubstantiated cures. A FDA analysis identified harmful levels of such as lead, mercury, and in unapproved Ayurvedic preparations, leading to documented cases of , including fatal lead toxicity reported in as recently as . Similarly, surveys of TCM products in have revealed widespread adulteration with undeclared pharmaceuticals or contaminants, with authenticity checks showing deliberate mislabeling to mimic legitimate remedies, undermining claims of safety and efficacy. These issues stem from lax enforcement in vast informal markets, where economic incentives prioritize volume over . Africa and Latin America exhibit high vulnerability during health crises, with herbal scams proliferating amid outbreaks. During the 2014 Ebola epidemic in West Africa, scammers promoted unproven "cures" like oils and extracts, exploiting panic and limited access to verified treatments, as warned by health authorities. WHO data indicate that over 80% of Africans rely on traditional healers, with substandard or falsified products comprising up to 10-30% of circulating medicines in low-income settings per global surveys, often lacking active ingredients or containing toxins. In Latin America, similar patterns emerge with informal markets, though quantitative data on rates remain sparse; economic pressures and regulatory gaps sustain these practices, delaying evidence-based interventions. Overall, WHO reports highlight that at least 1 in 10 medical products in these regions is substandard or falsified, correlating with traditional medicine's dominance and posing causal risks of untreated progression of diseases.

Digital Platforms and Social Media Scams

Digital platforms have facilitated the proliferation of quackery by enabling influencers to promote untested products to vast audiences, often using deceptive testimonials and endorsements. In 2023, the U.S. () charged a marketer with manipulating reviews to inflate ratings for unproven products, misrepresenting consumer feedback to drive sales. This case highlighted how platforms like and amplify fraudulent claims through algorithmic promotion of high-engagement content, where false endorsements can reach millions rapidly. The 's subsequent 2024 final rule explicitly bans the creation, purchase, or dissemination of fake reviews and testimonials, imposing civil penalties up to $50,120 per violation to curb such practices. Wellness influencers in the have frequently endorsed dietary supplements lacking clinical validation, contributing to consumer harm through unsubstantiated efficacy claims. A 2024 analysis of posts by German influencers from 2021–2023 found widespread promotion of supplements with ingredients like unproven extracts, often ignoring safety data and regulatory warnings. Similarly, U.S. influencers have faced scrutiny for hawking products such as peptides and detox regimens without evidence of benefits beyond effects, exploiting platform algorithms that prioritize , anecdotal "success stories" over peer-reviewed studies. These tactics scale deception exponentially, as social media's shareable format allows to diffuse 6–10 times faster than on , per diffusion models of content spread. The exemplified social media's role in quackery, with platforms hosting rampant promotion of as an unproven antiviral treatment despite insufficient evidence. A U.S. survey of over 13,000 cases linked ivermectin self-use to endorsement of , with 6% of respondents reporting its ingestion influenced by online claims ignoring regulatory rejections by bodies like the FDA. analyses revealed politicized echo chambers accelerating false narratives, where initial hype from anecdotal reports overshadowed meta-analyses showing no mortality benefit. This led to poison control surges from improper dosing, underscoring causal risks of unverified digital endorsements. Emerging AI technologies pose escalating threats, with deepfakes enabling personalized scams by fabricating endorsements from trusted figures. In 2024, scammers deployed AI-generated videos impersonating physicians to advertise unapproved supplements, targeting vulnerable users via targeted ads on platforms like . Such tactics, which bypass human verification, have driven losses exceeding $200 million in early 2025 from deepfake-enabled schemes, including fake medical claims for benefits redirection. Unlike traditional quackery, AI scales fabrication at low cost, evading detection and amplifying through hyper-realistic content that exploits users' trust in visual .

Societal and Economic Impacts

Health and Financial Consequences

Individuals who forgo evidence-based treatments in favor of unproven therapies for treatable conditions experience significantly elevated risks of adverse outcomes, primarily due to opportunity costs associated with delayed or absent conventional care. A longitudinal of over 1.2 million U.S. adults with nonmetastatic cancers (, , colorectal) found that those opting exclusively for had a 2.5-fold higher all-cause mortality (adjusted 2.50, 95% 1.88-3.27) compared to those receiving conventional treatments, with five-year survival rates dropping to 58.1% versus 86.6% for patients. Similar patterns emerge in other treatable diseases, where reliance on quackery correlates with progression to advanced stages, as patients miss windows for effective interventions like or . Financially, quackery imposes substantial direct costs on consumers through expenditures on ineffective products and services, diverting resources from validated medical care. In the United States, annual out-of-pocket spending on exceeded $34 billion in 2024, encompassing therapies and supplements often lacking rigorous evidence of efficacy beyond effects. These costs represent opportunity losses, as funds spent on quack remedies—such as unproven cures or devices—cannot be redirected toward proven diagnostics or treatments, exacerbating personal financial strain particularly among vulnerable populations. Quackery's propagation of further erodes public trust in established medicine, amplifying indirect health and economic burdens through behaviors like . The 1998 Wakefield study, later exposed as fraudulent, triggered a decline in UK MMR coverage from approximately 92% pre-1998 to 80% by 2003-2004, resulting in over 1,100 cases that year and subsequent outbreaks requiring costly responses. This distrust spillover effect heightens morbidity from preventable diseases, with longitudinal data linking such hesitancy to resurgences in vaccine-preventable illnesses and associated treatment expenses.

Role in Fostering Medical Skepticism

Exposure of quackery has historically catalyzed institutional reforms that elevate medical standards, thereby cultivating a disciplined toward unverified claims. The 1910 , authored by educator under the Carnegie Foundation, documented pervasive quackery in American medical education, where many of the 155 existing schools lacked scientific rigor, admitted unqualified students, and propagated pseudoscientific practices. This critique prompted the closure of over half of U.S. medical schools by 1923, enforced stricter licensing, and shifted curricula toward laboratory-based, evidence-driven training, reducing the prevalence of fraudulent therapies and restoring professional credibility. Such reforms demonstrated that confronting systemic flaws through empirical scrutiny strengthens medicine's foundations, encouraging practitioners and the public to prioritize verifiable outcomes over anecdotal promises. By systematically debunking fraudulent practices, efforts against quackery instill a broader epistemic discipline that demands causal evidence for all interventions, countering both overt scams and unsubstantiated mainstream assertions without eroding faith in validated science. Organizations dedicated to this pursuit, such as , analyze pseudoscientific claims using principles of scientific plausibility and controlled trials, equipping individuals to evaluate therapies independently. This approach fosters resilience against overpromising pharmaceuticals—evident in cases like the 2004 Vioxx withdrawal after hidden cardiovascular risks emerged—by promoting uniform standards of proof that apply across alternative and conventional modalities. Empirical scrutiny thus builds public capacity for discerning valid innovations from hype, as seen in regulatory responses like the FDA's 2000 rules clarifying permissible structure/function claims on dietary supplements, which require substantiation to mitigate misleading labels. Transparency measures post-exposure further aid restoration by institutionalizing , enabling to evolve into informed rather than wholesale . For instance, post-Flexner correlated with a decline in frauds, as state boards adopted uniform competency exams, verifiable through licensure data showing improved training outcomes by the 1930s. Similarly, ongoing anti-quackery advocacy has supported laws mandating for health claims, reducing the marketplace dominance of unproven remedies and reinforcing causal realism in patient . This dynamic underscores how vigilance against quackery refines medical , yielding a populace adept at questioning orthodoxy while upholding empirical benchmarks.

References

  1. [1]
    Art in Science: Quackery and Promises Not Kept - PMC - NIH
    Jun 21, 2022 · This longstanding pattern of fraudulence, of trickery, of prey is commonly referred to in the Western world as “quackery” [10, 13]. The term “ ...Missing: definition sources
  2. [2]
    Medical Quackery: The Pseudo-Science of Health and Well-Being
    Medical quackery in the United States dates to the earliest days of the colonies when medical practice was broadly defined and poorly regulated.Missing: origins | Show results with:origins
  3. [3]
    Quackery as a Public Health Problem - Oxford Bibliographies
    Aug 20, 2024 · Quackery is a largely neglected social pathology and public health menace. The harm to consumers can include: (1) direct harm when treatments ...
  4. [4]
    Causes and consequences of quack medicine in health care
    Jan 11, 2024 · [PMC free article] [PubMed] [Google Scholar]; 21. Jarvis WT, Quackery The national council against health Fraud perspective. Rheumatic ...
  5. [5]
    Causes and consequences of quack medicine in health care
    Jan 11, 2024 · Consequences of quack medicine. Based on the findings of this research, the consequences of quackery in the healthcare industry are divided into ...
  6. [6]
    The appeal of medical quackery: A rhetorical analysis - ScienceDirect
    Quackery, also called pseudo-medicine and medical fraud, means advertisement and offering of services and products using unscientific promises about efficacy ...
  7. [7]
    Quacksalver - Etymology, Origin & Meaning
    Originating in the 1570s from "quack," this word means one who boasts of medical skill, often a fraudulent or charlatan healer.
  8. [8]
    Quacks, Plagues, and Pandemics | Science History Institute
    Dec 15, 2020 · Even legitimate medicines can be tainted by quackery. The antimalarial drug chloroquine (and its variant hydroxychloroquine) was touted as a “ ...Missing: definition sources
  9. [9]
    Quack - Etymology, Origin & Meaning
    "medical charlatan, impudent and fraudulent pretender to medical skill," 1630s, short for quacksalver (1570s), from obsolete Dutch quacksalver (modern ...
  10. [10]
    Quackery - Etymology, Origin & Meaning
    "medical charlatan, impudent and fraudulent pretender to medical skill," 1630s, short for quacksalver (1570s), from obsolete Dutch quacksalver (modern ...
  11. [11]
    Charlatan - Etymology, Origin & Meaning
    Originating from 1610s French charlatan, from Italian ciarlatano meaning "a quack," charlatan means one who pretends to knowledge, skill, or importance.
  12. [12]
    CHARLATAN Definition & Meaning - Merriam-Webster
    Sep 1, 2025 · The Italian word for “to chatter” is ciarlare, and chattering was so associated with the cerretano that the spelling of the word shifted to ...
  13. [13]
    Ads and Labels From Early 20th-Century Health Fraud Promotions
    In the 1910s, the American Medical Association fought quackery promoted in pamphlets for drugs and treatments for everything from teething to epilepsy.
  14. [14]
    Quacks: Fakers and Charlatans in English Medicine - PMC - NIH
    Quackery, after all, was a highly visual art. The 17th century definition of a quack as someone who “pretends to have medical skill or knowledge” is ...
  15. [15]
    A history of aspirin - The Pharmaceutical Journal
    Sep 26, 2014 · Willow is used as a medicine by ancient civilisations like the Sumerians and Egyptians. The Ebers papyrus, an ancient Egyptian medical text ...
  16. [16]
    Historical perspective of aspirin: A journey from discovery to clinical ...
    Moreover, around 1300-1500 BC, some therapeutic effects of the willow and myrtle extractions, were found by Egyptians, to use for colic, gout, and earache ...
  17. [17]
    Ancient Rome - Medicine
    Many were illiterate, quacks, charlatans, and usually cheated the poor and needy. Today, looking at the medical practices of the Romans, a doctor would probably ...
  18. [18]
    Romans Bought Gladiator Sweat as Medicine - YouTube
    Jul 10, 2025 · Gladiator sweat was once the Roman version of luxury serum ... Romans Bought Gladiator Sweat as Medicine | Ancient Skincare… or Scam?<|separator|>
  19. [19]
    The Black Death (10 Medieval Cures) - TheCollector
    Dec 16, 2021 · Other so-called “cures” were quackery, or fuelled by religious fear-mongering. Medicine and the Black Death in the Medieval Period. woodcut ...
  20. [20]
    POPULAR MEDICAL KNOWLEDGE IN FOURTEENTH CENTURY ...
    ' 92. Jusserand. 93 gives an excellent account of the itinerant quacks of the fourteenth century who established themselves on the village green at holiday ...
  21. [21]
    Charlatans in the Early Modern Medical Marketplace - H-Net Reviews
    Here he takes a postmodern approach to the problem by exploring the different discourses on charlatans that existed in early modern Italy. We meet the charlatan ...Missing: quackery | Show results with:quackery
  22. [22]
    Quacks in Early Modern Europe - Nursing Outtakes
    Quacks are the greatest liars in the world except their patients. Benjamin Franklin. Quack, in the sense of a medical impostor, is a shortening of the old Dutch ...
  23. [23]
    Hippocrates and willow bark? What you know about the history of ...
    Oct 18, 2020 · He described willow as a remedy for stomach ache, the respiratory disease tuberculosis, and as a contraceptive. He said if you burned willow ...
  24. [24]
    Balm of America: Patent Medicine Collection - History
    Patent medicines often contained dangerous levels of alcohol, opium, and other potentially deadly and addictive narcotics, as shown here on the label of ...Missing: statistics | Show results with:statistics
  25. [25]
    History of Patent Medicine - Hagley Museum
    By the middle of the 19th century the manufacture of similar products had become a major industry in America. Often high in alcoholic content, these remedies ...Missing: boom statistics
  26. [26]
    Pure Food and Drugs - National Library of Medicine - NIH
    The law forbade adulteration and misbranding of foods, drinks, and drugs in interstate commerce but contained few specific requirements to insure compliance.
  27. [27]
    Patent Medicines in Historical Newspapers
    The tablets and tonics ranged from ineffective to deadly, and often contained dangerous, undisclosed ingredients like opium and lead. Loading. 1902 Biologics ...
  28. [28]
    The Medical Messiahs: Chapter 7 - Quackwatch
    Jan 4, 2002 · Dr. Cramp and the American Medical Association fought not only the most unscrupulous of quacks. They opposed virtually all proprietary preparations with secret ...
  29. [29]
    The doctor said it could cure cancer. The federal chemist proved that ...
    Aug 26, 2017 · What exactly was Krebiozen? That's what Alma Levant Hayden had to find out. Hayden was a chemist at the Food and Drug Administration and an ...Missing: treatment 1960s
  30. [30]
    How A Little Science And A Lot Of Shady Advertising Boosted ... - NPR
    Dec 28, 2018 · Brewer's yeast isn't a new health fad; it was likely the first faddish health food to gain widespread popularity after the existence of ...Missing: quackery 1950s<|separator|>
  31. [31]
    Laetrile/Amygdalin (PDQ®)–Health Professional Version
    Jun 14, 2022 · Laetrile (Amygdalin) has shown little anticancer activity in animal studies and no anticancer activity in human clinical trials.
  32. [32]
    Laetrile treatment for cancer - PMC - PubMed Central - NIH
    Laetrile is the name for a semi‐synthetic compound which is chemically related to amygdalin, a cyanogenic glycoside from the kernels of apricots and various ...
  33. [33]
    A Randomized Trial of Hydroxychloroquine as Postexposure ...
    Jun 3, 2020 · Hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure.
  34. [34]
    Misguided Use of Hydroxychloroquine for COVID-19 - JAMA Network
    Nov 9, 2020 · The results conclusively show no benefit of hydroxychloroquine over placebo. Several published rigorous studies have demonstrated similar findings.Missing: large- | Show results with:large-
  35. [35]
    6 Tip-offs to Rip-offs: Don't Fall for Health Fraud Scams | FDA
    Mar 4, 2021 · “All natural” cure or treatment. Don't be fooled by descriptions like "all-natural cure." Such phrases are often used in health fraud as an ...
  36. [36]
    Pseudoscience in medicine: cautionary recommendations - PMC
    ' These examples are taken to represent pseudoscience in medicine, which is defined here as scientific denialism associated with moral failure, justifying ...
  37. [37]
    Quantum terminology in pseudoscience: exploration of pre-service ...
    Aug 7, 2025 · These responses emphasized that the text not only misused jargon but also fundamentally lacked a scientific basis. One participant observed ...1 Introduction · 2 Methods · 3 ResultsMissing: pseudomedicine | Show results with:pseudomedicine
  38. [38]
    Is multi-level marketing of nutrition supplements a legal ... - PubMed
    While considering that MLM of dietary supplements and other nutrition products are a legal business strategy, we affirm that it is an unethical practice.
  39. [39]
    Buyers and Sellers Alike Need to Beware of Multilevel-Marketed ...
    Dec 4, 2000 · Some multilevel marketing programs are illegal pyramid schemes. A focus upon new distributor recruitment in hopes of sharing in their ...
  40. [40]
    2020 Recalls - Health Fraud - FDA
    Feb 18, 2021 · 03/24/2020, Platinum, Slimming Plus and more, Marketed as a dietary supplement, Unapproved new drug; contains undeclared sildenafil, sibutramine ...Missing: 2020s | Show results with:2020s
  41. [41]
    Recalls, Market Withdrawals, & Safety Alerts - FDA
    The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products.Major Product Recalls · Undeclared Peanut Allergen · FDA.gov ArchiveMissing: 2020s | Show results with:2020s
  42. [42]
    The appeal of medical quackery: a rhetorical analysis - PubMed
    Countering today's pseudo-medicine begins with an examination of what makes patients susceptible to the claims of quack medicine. Understanding why patients are ...Missing: desperation hope naturalism bias
  43. [43]
    Alternative Therapy: An Historical Perspective on Health Fraud
    Dec 15, 2019 · Most people think that quackery and health frauds are easy to spot. They are wrong. Quack promoters can appeal to every aspect of human ...
  44. [44]
    The naturalness bias - PubMed
    Aug 20, 2025 · Some people report preferring a natural item like a drug even when it is objectively less safe or effective than a synthetic counterpart. This ...
  45. [45]
    The Naturalness Bias Influences Drug and Vaccine Decisions ...
    The naturalness bias is a preference for natural drugs/vaccines over synthetic ones, even when identical, and occurs across cultures, with Chinese showing ...
  46. [46]
    Alternative Medicine Is a $34 Billion Industry, But Only One-Third of ...
    Jun 18, 2013 · As USA Today reports, many American consumers cite distrust of big pharmaceutical companies as one of the main reasons they lean towards using ...
  47. [47]
    Are alternative practitioners fear-mongers? - Edzard Ernst
    Jun 5, 2017 · Here are a few of the strategies they use for their fear-mongering. ... medicine also engages in fear-mongering. Not for profit, in the way ...Missing: tactics testimonials<|separator|>
  48. [48]
    NIH analysis reveals a significant rise in use of complementary ...
    Jan 31, 2024 · The percentage of individuals who reported using at least one of the seven approaches increased from 19.2% in 2002 to 36.7% in 2022. · The use of ...
  49. [49]
    Education level, interest in alternative medicine among factors ...
    Mar 1, 2021 · People with lower education or health literacy levels, a tendency to use alternative medicine or a distrust of the health care system are more likely to ...
  50. [50]
    Advertising and Science: The Exaggerations of Quackery
    section examines the status of consumer testimonials in libel and fraud litigation. Testimonials were the most important advertising strategy of quacks, ...
  51. [51]
  52. [52]
    How Snake Oil Became a Symbol of Fraud and Deception
    Oct 21, 2024 · In his ads, Stanley described his snake oil as “the strongest and best liniment known for pain and lameness,” providing “immediate relief,” “ ...
  53. [53]
    Clark Stanley's Snake Oil Liniment | Smithsonian Institution
    According to his own account, Clark Stanley was born in Texas, ca. 1854, and worked as a cowboy for several years. Then, while studying with a Hopi medicine ...
  54. [54]
    The history of snake oil - The Pharmaceutical Journal
    Jan 23, 2015 · In 1915 the US government ordered the analysis of a well-known product, Clark Stanley's Snake Oil Liniment. The analyst found that its main ...
  55. [55]
    Term 'snake oil salesman' has roots in California's history
    Dec 11, 2016 · Stanley was prosecuted and fined in 1917 under the Pure Food and Drug Act of 1906 for selling patent medicine that contained mineral oil, ...<|separator|>
  56. [56]
    Lydia Pinkham's Vegetable Compound (1873-1906)
    May 20, 2017 · First marketed in the US 1875, Lydia Pinkham's Vegetable Compound was an herbal medicine used by women to relieve menstrual discomfort and ...
  57. [57]
    Lydia Pinkham Sells a Vegetable Compound (With a Little Booze In It)
    Of all the patent medicines of the 19th century, Mrs. Lydia Pinkham Vegetable Compound, made of alcohol and herbs, was perhaps the best known.
  58. [58]
    Cautionary Tales – the true scandal of Lydia E. Pinkham's vegetable ...
    Apr 14, 2023 · Lydia E. Pinkham's Vegetable Compound was, in fact, just a concoction of herbs and alcohol of no proven medicinal merit.
  59. [59]
    Behind the pep: Modern and postmodern perspectives in Lydia E ...
    Jan 30, 2017 · In the late 19th century, Pinkham began concocting the herbal remedy in her home in Lynn, Massachusetts, to treat menstrual cramps, headaches, “ ...
  60. [60]
    Radithor and the era of mild radium therapy - PubMed
    Aug 1, 1990 · Radithor was advertised as an effective treatment for over 150 endocrinologic diseases, especially lassitude and sexual impotence.Missing: AMA 1900-1920
  61. [61]
    Radithor (ca. 1928) | Museum of Radiation and Radioactivity
    Radithor is one of the few radioactive quack cures that can be unambiguously linked to someone's death. Donated by Roger Macklis and David Allard.Missing: 1900-1920 | Show results with:1900-1920
  62. [62]
    [PDF] Copyright by Robert Wendell Holmes III 2010
    The AMA continued to publish reports on the worst patent medicine offenders in. JAMA. A third volume of Nostrums and Quackery, the Association's compendium ...
  63. [63]
    [PDF] John R. Brinkley: A Quintessential American Quack
    Sep 9, 2022 · In September 1930, the board revoked Brinkley's Kansas medical license for “gross immorality” and “unprofessional conduct.”1 Sepa- rately, but ...Missing: promotion | Show results with:promotion<|separator|>
  64. [64]
    The Doctor Who Convinced America That a Goat-Ball Transplant ...
    Apr 2, 2022 · Brinkley began charging $750 for a goat-gland transplant, equivalent to around $16,500 today. ... Tax evasion charges and mail fraud charges ...<|separator|>
  65. [65]
    John R. Brinkley Got Rich on Glandular Gullibility - HistoryNet
    Sep 19, 2018 · Physicians testified that Brinkley's goat-gland and prostate operations were frauds and that “medicines” he hawked were mostly water and dye.Missing: evidence | Show results with:evidence
  66. [66]
    Goat Gland Doctor (1986) - Texas Archive of the Moving Image
    The verdict unleashed a number of lawsuits against Brinkley for malpractice, wrongful death, and fraud. The disgraced doctor also became the subject of federal ...Missing: evidence | Show results with:evidence
  67. [67]
    American Inquisition: The FDA's Persecution of Wilhelm Reich
    Jan 1, 1980 · In published articles Reich claimed successful treatment of cancer, leukemia, and other diseases. As word of the "orgone boxes" spread, Reich's ...
  68. [68]
    Wilhelm Reich, 1897-1957 - Mary Ann Liebert, Inc.
    orgone energy. 1956 In May, Dr. Reich found guilty of disobeying injunction following a jury trial; sentenced to two years in prison; Wilhelm Reich ...<|separator|>
  69. [69]
    DR. REICH AND AIDE SENTENCED TO JAIL - The New York Times
    Drs Reich and Silvert sentenced to jail for contempt for failure to comply with Fed injunction barring interstate shipment of accumulators and distribution ...
  70. [70]
    Wilhelm Reich: Twice Burned - JSTOR Daily
    Dec 8, 2024 · In 1956, Reich was charged with contempt for violating the injunction and sentenced to two years in prison. The court also ordered that Reich's ...Missing: trials | Show results with:trials
  71. [71]
    The Case of Wilhelm Reich | Charles Rycroft
    Nevertheless, it can be said with some assurance that two features of Reich's analytical work failed to have much impact on the psychoanalytical establishment.
  72. [72]
    Medicines legislation and regulation in the United Kingdom 1500 ...
    This Act gave regulatory powers to Examiners from the King and Queen's College of Physicians of Dublin to ensure the quality of drugs, medicines, oils and ...
  73. [73]
    Medicines legislation and regulation in the United Kingdom 1500 ...
    Aug 17, 2022 · The Pharmacy Act 1852, and the related Acts of 1868 and 1908, left enforcement of the law and control of the sale of poisons in the hands of the ...
  74. [74]
    From Prussia to Russia: Russian critics of “Aerztliche Ethik” - PMC
    Dec 31, 2019 · ... quackery), to a patient and to another physician. See also a book by A. - H. Maehle on German medical courts of honor (11). It is ...
  75. [75]
    The Long Struggle for the Law - FDA
    Feb 6, 2018 · The 1906 law forbade interstate and foreign commerce in adulterated and misbranded food and drugs. Offending products could be seized and condemned.<|separator|>
  76. [76]
    Patent-Medicine Exposures Before and After the Pure Food and ...
    May 20, 2020 · This monograph examines magazine coverage of patent medicines before and after the Pure Food and Drug Act of 1906 became law. Patent medicines ...
  77. [77]
    Promoting Safe & Effective Drugs for 100 Years - FDA
    Apr 23, 2019 · This amendment created requirements that certain drugs be labeled for sale by prescription only. The Kefauver-Harris Drug Amendments. In 1962, ...
  78. [78]
    Reform, Regulation, and Pharmaceuticals — The Kefauver–Harris ...
    in the form of “adequate and well-controlled investigations”— before ...
  79. [79]
    Health Fraud Product Database - FDA
    This list includes unapproved products that have been subject to FDA health fraud related violations. These products have been cited in warning letters.
  80. [80]
    Warning Letters - Health Fraud - FDA
    Aug 27, 2025 · Examples of FDA Warning Letters that cite unapproved or unsubstantiated claims, tainted products or other health fraud - related violations.
  81. [81]
    Federal Trade Commission Cracks Down On Unproven COVID-19 ...
    Nov 12, 2020 · Congressman Calls For Federal Crackdown On Unproven Coronavirus Treatment ... FDA and FTC need additional resources to combat the glut of ...Missing: 2020s | Show results with:2020s
  82. [82]
    FDA, FTC warn companies selling fraudulent coronavirus covid-19 ...
    Mar 9, 2020 · Federal officials announced Monday a crackdown against companies selling products claiming to prevent, treat or cure covid-19, the disease caused by the new ...<|separator|>
  83. [83]
    Health Products Compliance Guidance - Federal Trade Commission
    Dec 20, 2022 · Since 1998, the FTC has settled or adjudicated more than 200 cases involving false or misleading advertising claims about the benefits or safety ...Missing: quackery | Show results with:quackery
  84. [84]
    [PDF] COMBATING FALSIFIED MEDICAL PRODUCT-RELATED CRIME
    This Guide was developed in response to Commission on Crime Prevention and Criminal Justice resolution. 20/6, entitled “Countering fraudulent medicines, in ...
  85. [85]
    Home | Ministry of Ayush, Govt. of India
    Ayush Oushadhi Gunvatta Evam Uttpadan Samvardhan Yojana. Regulation of Ayurveda, Siddha, Unani and Homeopathy (ASU&H) medicines in India, are governed under the ...
  86. [86]
    [PDF] government of india ministry of ayush rajya sabha unstarred ...
    Mar 25, 2025 · Rule. 158-B in the Drugs Rules, 1945 provides the regulatory guidelines for issue of license to manufacture Ayurvedic, Siddha, Unani ...<|separator|>
  87. [87]
    New WHO and Ministry of AYUSH, Republic of India agreement ...
    Nov 17, 2023 · New WHO and Ministry of AYUSH, Republic of India agreement signed to advance traditional, complementary, and integrative medicine. 17 ...
  88. [88]
    Thirty-one years of Pharmaceutical Industry Criminal and Civil ...
    From 1991-2021, the federal and state governments entered into 482 settlements with pharmaceutical manufacturers, totaling $62.3 billion in financial penalties.
  89. [89]
    Justice Department Announces Largest Health Care Fraud ...
    Sep 2, 2009 · Pfizer have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil ...
  90. [90]
    pharmaceutical industry summary page - Violation Tracker
    Top 10 Current Parent Companies, Total Penalty $, Number of Records. Johnson & Johnson, $25,117,910,922, 81. GSK plc, $11,777,303,406, 52.
  91. [91]
    Health Fraud Scams - FDA
    The U.S. FDA sent abuse complaints to registrars managing websites that offer any unapproved drugs or uncleared devices, or potentially counterfeit, controlled, ...Health Fraud Product Database · Cosmetic Products Containing... · Tianeptine
  92. [92]
    Alternative Medicine for Cancer Treatment Raises Mortality Risk - NCI
    Sep 12, 2017 · Choosing alternative medicine as an initial cancer treatment led to substantially worse survival than patients who received conventional ...Missing: meta- 2010s
  93. [93]
    Steve Jobs Regretted Delaying Cancer Surgery 9 Months ...
    Oct 20, 2011 · Steve Jobs told his biographer, Walter Isaacson, that he put off surgery for pancreatic cancer for nine months, and later regretted it.Missing: evidence | Show results with:evidence
  94. [94]
    Alternative Medicine & The Death of Steve Jobs | Psychology Today
    Oct 21, 2011 · Despite pleading from his distressed family, friends and physicians, Steve chose to delay surgery and chemotherapy for 9 months. When dealing ...
  95. [95]
    Complementary And Alternative Medicine Market Size, 2033
    The global complementary and alternative medicine market size was estimated at USD 179.17 billion in 2024 and is projected to reach USD 1430.70 billion by 2033, ...
  96. [96]
    FTC Sends Cease and Desist Demands to 10 Companies ...
    Sep 9, 2021 · The Federal Trade Commission sent cease-and-desist letters to 10 companies suspected of advertising unproven treatments or cures for diabetes.Missing: recoveries | Show results with:recoveries
  97. [97]
    Looking back at the lawsuit that transformed the chiropractic ... - NIH
    The AMA undertook a program of containment by preventing chiropractic growth and licensure. They encouraged ethical complaints against doctors of chiropractic ...
  98. [98]
    Chiropractic's Fight for Survival - AMA Journal of Ethics
    Jun 14, 2011 · It took an antitrust lawsuit filed against the AMA in 1976 to reveal the magnitude and scope of the AMA's plan. Despite generations of organized ...
  99. [99]
    WILK V. AMA 25 YEARS LATER: WHY IT STILL ISN'T OVER
    ... American Medical Association (AMA) guilty of conspiring to destroy chiropractic. [1] Early History The nefarious plot was hatched in 1962 when the Iowa Plan ...
  100. [100]
    Effect of Usual Medical Care Plus Chiropractic Care ... - JAMA Network
    May 18, 2018 · Conclusions and Relevance Chiropractic care, when added to usual medical care, resulted in moderate short-term improvements in low back pain ...
  101. [101]
    Benefits and harms of spinal manipulative therapy for the treatment ...
    Mar 13, 2019 · Conclusion SMT produces similar effects to recommended therapies for chronic low back pain, whereas SMT seems to be better than non-recommended ...
  102. [102]
    Acupuncture for Chronic Pain: Individual Patient Data Meta-analysis
    Sep 10, 2012 · In conclusion, we found acupuncture to be superior to both no-acupuncture control and sham acupuncture for the treatment of chronic pain.
  103. [103]
    Pharmaceuticals/Health Products Lobbying Profile - OpenSecrets
    Trump moves against direct-to-consumer drug ads despite massive lobbying by pharmaceutical industry. Influence & Lobbying October 08, 2025. View all ...
  104. [104]
    How the public is being misled about complementary/alternative ...
    Proponents of CAM often claim that their treatments are victims of a well-coordinated attack by 'big pharma' and 'the scientific establishment'. They seem to ...
  105. [105]
    Impact of regulatory science on global public health - PMC
    Jul 9, 2012 · FDA estimated that Vioxx contributed to approximately 28,000 heart attacks and sudden cardiac deaths between 1999 and 2003. ... recall ...
  106. [106]
    Drug Overdose Deaths in the United States, 1999–2020 - CDC
    Dec 30, 2021 · In 2020, 91,799 drug overdose deaths occurred in the United States for an age-adjusted rate of 28.3 per 100,000 standard population (Figure 1).
  107. [107]
    Opioid Facts and Statistics - HHS.gov
    Dec 16, 2022 · More than 760,000 people have died since 1999 from a drug overdose. Nearly 75% of drug overdose deaths in 2020 involved an opioid. Explore drug ...Missing: total | Show results with:total
  108. [108]
    [PDF] Artemisinin - A Gift from Traditional Chinese Medicine to the World
    I would like to thank the Nobel Assembly and the Nobel Foundation for awarding me the 2015 Nobel Prize in Physiology or Medicine. ... Tu Youyou et al.
  109. [109]
    FDA and Cannabis: Research and Drug Approval Process
    Feb 24, 2023 · The agency has, however, approved one cannabis-derived drug product: Epidiolex (cannabidiol), and three synthetic cannabis-related drug products ...
  110. [110]
    [PDF] NDA 215455 - FDA
    Jun 4, 2024 · Breakthrough Therapy Designation for midomafetamine for the treatment of PTSD was granted on. August 15, 2017. Initially the MAPP1 protocol ...Missing: 2020s | Show results with:2020s
  111. [111]
    MDMA-Assisted Therapy for Post-Traumatic Stress Disorder - PubMed
    Early-phase clinical trials of MDMA-assisted therapy (MDMA-AT) showed promising results, leading the FDA to grant breakthrough therapy status to MDMA-AT in 2017 ...Missing: 2020s | Show results with:2020s
  112. [112]
    Prevalence and factors associated with use of herbal medicines ...
    Oct 6, 2016 · It is estimated that 80 % of the population living in rural areas in developing countries depends on traditional medicine for their health needs ...
  113. [113]
    FDA warns about heavy metal poisoning associated with certain ...
    Oct 2, 2023 · Use of unapproved ayurvedic drug products containing harmful levels of heavy metals may cause heavy metal poisoning and a range of health ...Missing: adulterated 2020s
  114. [114]
    Lead toxicity from Ayurvedic medicines - CMAJ
    Aug 8, 2023 · Use of Ayurvedic medications is relatively common; these medications may be contaminated with lead and other heavy metals.
  115. [115]
    Assesment of Adulterated Traditional Chinese Medicines in China
    Nov 29, 2019 · This research intends to identify those TCMs vulnerable to adulteration, to list common adulterants, and to characterize the techniques of analysis.
  116. [116]
    ​Ebola crisis spurs rash of scams - CBS News
    Oct 20, 2014 · The Ebola epidemic is spurring a swarm of scams that promote bogus "cures," fund fake charities and spread computer viruses aimed at ...
  117. [117]
    Agencies Issue Warnings Over Bogus Ebola Cures
    Aug 15, 2014 · Panic over Ebola has the makers of dietary supplements aggressively targeting Africans, claiming to have a cure for the lethal virus.
  118. [118]
    1 in 10 medical products in developing countries is substandard or ...
    Nov 28, 2017 · An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new ...Missing: traditional | Show results with:traditional
  119. [119]
    Substandard and falsified medical products
    Dec 3, 2024 · At least 1 in 10 medicines in low- and middle-income countries are substandard or falsified. Countries spend an estimated US$ 30.5 billion per ...Missing: traditional | Show results with:traditional
  120. [120]
    [PDF] Traditional Health Systems in Latin America and the Caribbean
    traditional healing, ten percent of the traditional healers have managed to get a permit. In order to get this permit, traditional healers need to go through ...
  121. [121]
    FTC Charges Supplement Marketer with Hijacking Ratings and ...
    Feb 16, 2023 · The FTC's complaint alleges that by manipulating product pages, Bountiful misrepresented the reviews, the number of Amazon reviews and the ...
  122. [122]
    Federal Trade Commission Announces Final Rule Banning Fake ...
    Aug 14, 2024 · The Federal Trade Commission today announced a final rule that will combat fake reviews and testimonials by prohibiting their sale or purchase.
  123. [123]
    Disinformation on dietary supplements by German influencers on ...
    Nov 25, 2024 · In this paper, the ingredients of 105 dietary supplements promoted by German influencers on Instagram from 2021 to 2023 were analyzed.Missing: wellness untested 2020s
  124. [124]
    Spread of misinformation on social media: What contributes to it and ...
    Given the importance of these questions to misinformation research, this study aims to (a) provide a systematic and structured overview of the factors that ...
  125. [125]
    Misinformation, Trust, and Use of Ivermectin and ... - JAMA Network
    Sep 29, 2023 · Among 13 438 adults in a 50-state US survey study who reported probable or definite COVID-19 infection, 6% reported use of either ivermectin or ...
  126. [126]
    The Politicization of Ivermectin Tweets During the COVID-19 ... - NIH
    We explore the ivermectin discourse and sentiment in the United States with a special focus on political leaning through the social media blogging site Twitter.
  127. [127]
    A cross-lingual analysis on the spread of misinformation using the ...
    Sep 6, 2023 · This study observes misinformation on Twitter in the Japanese and English languages regarding false claims that the drug Ivermectin is an effective treatment ...
  128. [128]
    Scammers using AI-generated videos of doctors to peddle ...
    Dec 9, 2024 · Health professionals are being impersonated in deepfake videos promoting dietary supplements for the treatment of type 2 diabetes.
  129. [129]
    The Rise of the AI-Cloned Voice Scam - American Bar Association
    Sep 10, 2025 · Global losses from deepfake-enabled fraud reached over $200 million in Q1 2025 alone. In early 2024, a UK-based energy firm lost €220,000 ...
  130. [130]
    U.S. Complementary And Alternative Medicine Market Report, 2030
    The U.S. complementary and alternative medicine market size was estimated at USD 34.40 billion in 2024 and is projected to grow at a CAGR of 23.9% from 2025 ...
  131. [131]
    [PDF] 1998 Wakefield MMR Controversy
    1998 – 2000's. Becomes a political issue in. UK. 2004 - 2010. Brian Deer. Investigation. 2000 onward. MMR coverage in UK drops to. 80% in 2003-. 04, 1144 cases.
  132. [132]
    Fifteen Years After A Vaccine Scare, A Measles Epidemic - NPR
    May 22, 2013 · Childhood vaccination rates plummeted in Great Britain after a 1998 paper by Dr. Andrew Wakefield claimed that the vaccine for measles, mumps ...
  133. [133]
    The revolution of Abraham Flexner and its aftermath
    Nov 17, 2020 · The Flexner Report3,4 created a revolution and remade medical education in the United States. It exposed medical quackery, and made ...
  134. [134]
    [PDF] Reproductions supplied by EDRS are the best that can be ... - ERIC
    May 17, 2000 · His 1910 Flexner Report created a revolution, remade medical education in the U.S. and beyond, exposed medical quackery, made science,.
  135. [135]
    Flexner Report Transformed Med Schools - NPR
    Aug 16, 2008 · A hundred years ago you were just as likely to get your meds from a carpet-bagging quack as from a doctor. Then along came Abraham Flexner, not ...
  136. [136]
    Quackery: The National Council Against Health Fraud Perspective
    Sep 19, 2018 · Quackery is the promotion of false and unproven health schemes for a profit. It is rooted in the traditions of the marketplace.
  137. [137]
    [PDF] Federal Register/Vol. 65, No. 4/Thursday, January 6, 2000/Rules ...
    Jan 6, 2000 · The regulations also establish criteria for determining when a statement about a dietary supplement is a claim to diagnose, cure, mitigate, ...
  138. [138]
    The Book Natural Healers Really Hate | Office for Science and Society
    Aug 16, 2024 · The Flexner Report helped change medical education in North America. ... The kind of quackery that Flexner decried has not really gone away ...
  139. [139]
    Guidance for Industry: Substantiation for Dietary Supplement Claims ...
    Sep 20, 2018 · This guidance document is intended to describe the amount, type, and quality of evidence FDA recommends a manufacturer have to substantiate a claim under ...